Advanced search
1 file | 155.89 KB Add to list

Scheduled maintenance: Publication downloads temporarily unavailable.

Due to maintenance publication downloads will not be available on:

  • Wednesday, March 27, 17:00 – 21:00
  • Thursday, March 28, 17:00 – 21:00

Exports of lists, FWO and BOF information will remain available.

For any questions, please contact biblio@ugent.be. Apologies for any inconveniences, and thank you for your understanding.

The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy : results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial

(2003) EUROPEAN UROLOGY. 44(4). p.423-428
Author
Organization
Keywords
adverse effects, INTRAVESICAL BCG, efficacy, mycobacterium bovis, transitional cell carcinoma, RISK, bladder neoplasms, TUMORS, TOXICITY, URINARY INTERLEUKIN-8, METAANALYSIS, IMMUNOTHERAPY, THERAPY, TRANSITIONAL-CELL CARCINOMA

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 155.89 KB

Citation

Please use this url to cite or link to this publication:

MLA
Sylvester, Richard J., et al. “The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict Its Efficacy : Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.” EUROPEAN UROLOGY, vol. 44, no. 4, 2003, pp. 423–28, doi:10.1016/S0302-2838(03)00371-3.
APA
Sylvester, R. J., van der Meijden, A. P., Oosterlinck, W., Hoeltl, W., & Bono, A. V. (2003). The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy : results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial. EUROPEAN UROLOGY, 44(4), 423–428. https://doi.org/10.1016/S0302-2838(03)00371-3
Chicago author-date
Sylvester, Richard J, Adrian PM van der Meijden, Willem Oosterlinck, Wolfgang Hoeltl, and Aldo V Bono. 2003. “The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict Its Efficacy : Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.” EUROPEAN UROLOGY 44 (4): 423–28. https://doi.org/10.1016/S0302-2838(03)00371-3.
Chicago author-date (all authors)
Sylvester, Richard J, Adrian PM van der Meijden, Willem Oosterlinck, Wolfgang Hoeltl, and Aldo V Bono. 2003. “The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict Its Efficacy : Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.” EUROPEAN UROLOGY 44 (4): 423–428. doi:10.1016/S0302-2838(03)00371-3.
Vancouver
1.
Sylvester RJ, van der Meijden AP, Oosterlinck W, Hoeltl W, Bono AV. The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy : results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial. EUROPEAN UROLOGY. 2003;44(4):423–8.
IEEE
[1]
R. J. Sylvester, A. P. van der Meijden, W. Oosterlinck, W. Hoeltl, and A. V. Bono, “The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy : results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial,” EUROPEAN UROLOGY, vol. 44, no. 4, pp. 423–428, 2003.
@article{285259,
  author       = {{Sylvester, Richard J and van der Meijden, Adrian PM and Oosterlinck, Willem and Hoeltl, Wolfgang and Bono, Aldo V}},
  issn         = {{0302-2838}},
  journal      = {{EUROPEAN UROLOGY}},
  keywords     = {{adverse effects,INTRAVESICAL BCG,efficacy,mycobacterium bovis,transitional cell carcinoma,RISK,bladder neoplasms,TUMORS,TOXICITY,URINARY INTERLEUKIN-8,METAANALYSIS,IMMUNOTHERAPY,THERAPY,TRANSITIONAL-CELL CARCINOMA}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{423--428}},
  title        = {{The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy : results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial}},
  url          = {{http://doi.org/10.1016/S0302-2838(03)00371-3}},
  volume       = {{44}},
  year         = {{2003}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: